Brevetti EPO No.3897655 2024.07.17
Brevetti EPO
(10) Registration Number and Date
2024000425 2024.10.21
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2024/000425 2019.12.18
(40) Publication Number and Date
SM /T/2024/000425 2024.10.21
(30) Priority Details
EP 18306716
2018.12.18
(71/73) Applicant
(IT) INSTITUT NATIONAL DE LA SANTE ETDE LA RECHERCHE MEDICALE (INSERM) : 101, rue de Tolbiac, 75654 Paris Cédex 13, FR
(72) Inventor
(IT) MARIGHETTO, Aline : Neurocentre Magendie INSERM U1215 146, rue Léo Saignat, 33077 BORDEAUX, FR
(IT) MONLEZUN, Stéphanie : AELIS FARMA Neurocentre Magendie 146, rue Léo Saignat, 33077 BORDEAUX, FR
(IT) REVEST, Jean-Michel : AELIS FARMA Neurocentre Magendie 146, rue Léo Saignat, 33077 BORDEAUX, FR
(IT) OZAITA, Andrés : Laboratory of Neuropharmacology Universitat Pompeu Fabra, PRBB Dr Aiguader 88, 08003 BARCELONA, ES
(74) Representative Name
(IT) MONTEBELLI, Marco : Piazza E. Enriquez, 22c, 47891 Dogana RSM, SM
(54) Title
(IT) 3BETA-(BENZILOSSI)-17ALFA-METILPREGN-5-EN-20-ONE PER USO NEL TRATTAMENTO DI DISTURBI COGNITIVI
(EN) 3BETA-(BENZYLOXY)-17ALPHA-METHYL-PREGN-5-EN-20-ONE FOR USE IN THE TREATMENT OF COGNITIVE DISORDERS
(57) Abstract
(58) Citations